“…The successful use of granulocyte transfusions has been limited for years, however, by the inability to collect sufficient numbers of granulocytes from healthy donors 10,14 . The development of new‐generation blood cell separators (e.g., continuous collection), the use of sedimenting agents (e.g., hydroxyethyl starch [HES]), and the administration of corticosteroids as precollection treatment for donors permitted the collection of about 1 × 10 10 absolute neutrophils per unit 15,16 . There is evidence that only the precollection donor treatment with rHuG–CSF, a potent stimulating agent for myeloid progenitor cells, permits the harvest of the threshold dose of 4 × 10 10 absolute neutrophils 17,19 …”